object of this study was to determine the acute effects of fenoterol (Berotec) administered by a metered dose inhaler on ventilation/perfusion relationships as manifested by changes in blood gas composition and spiromehic values. Twelve patients from the Hines, IUinois VA Hospital and 12 patients from Northwestern Memorial Hospital, Chicago, were studied. The 24 patients were ambulatory and had previously been diagnosed as having bronchial asthma or asthmatic bmnchitis. All had reversible airway obstruction with an improvement of at least 15 percent in their forced expiratory volume in one sffond within 30 minutes following two inhalations of isoproterenol from a metered dose inhaler. Bronchodilator and antihistamine drug treatment was stopped at least 12 bours prior to the test drug admiaistration. Steroids were continued if the patient was using 10 mg daily or less. The majority of the patients were not using steroids. Isoproterenol and fenoterol were used in a double-blind cross-over comparison so that each patient served as his own control. The interval between tests was not less than 24 hours or more than one week. The total dose of fenoteml was 0.40 mg given as two inhalations of .20 mg each, and the total isopmterenol dose was 0.15 mg divided between two inhalations. Arterial blood and spiromehic measurements were made at base line and at 15,30,60,120 and 180 minutes following drug administration.
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Peak effects for both drugs ormrred at 15 minutes and were equal in magnitude. For all of the spiromehic measurements improvement following inhalation of fenoterol was maintained throughout the three-hour period of observation, whereas the improvement foUowing isoproterenol inhalation was maintained for only 30-60 minutes with little residual e6ect at two hours. The longer duration of action was endent in the FVC and FEV,, as well as in those tests indicative of small airway status-FEF 50 percent and FEF 75 percent. The average values for the decline in Po, were physiologically insignificant (2-5 nun Hg). The fan in Po, at 15 minutes following adminiskation of fenoteml was not statisticauy signii?cant, whereas the decline in Po, following isoproterenol was si&cant to three bours (Fig 1) . The declines were small, but in the occasional patient they were as p a t as 10 to 12 nun Hg. There was no signilicant change in pulse rate, blood pressure or PCO, at any of the time intervals for either drug.
The mechanism for the decline in arterial PO, following aerosol bronchodilator administration is uncertain. Although occasionally observed following isoproterenol, it was not observed in these 24 patients following administration of fenoteml in doses d c i e n t to produce significant and sustained improvement in expiratory airflow. 
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